ACC.26 advanced registration ends Feb. 12 – register now!

Larry S. Dean, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Teleflex(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Emageon(MODEST) RESEARCH/RESEARCH GRANTS: Edwards Life Sciences(SIGNIFICANT)

View Full Disclosure